this study provides direct evidence that de novo expression of the activation antigens b1 49.9 ( 49.9 ) ( interleukin-2 receptor ) and 4f2 enables identification of alloactivated cells within 18 hr of initiation of human mixed lymphocyte reactions ( mlr ) .
C1420192
4f2
C0086418
human